These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5371310)

  • 1. [Effects of biguanides on peripheral tissues].
    Butterfield WJ
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():644-55. PubMed ID: 5371310
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current views on the mode of action of blood glucose lowering biguanides].
    Segre G
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():627-35. PubMed ID: 4984396
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of but-biquanide on lactic acid metabolism in skeletal muscle of diabetic patients].
    Sensi S; Capani F; Caradonna P; Niccoli L
    Arzneimittelforschung; 1970 Jan; 20(1):142-7. PubMed ID: 5467437
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of oral treatment in diabetes].
    Romani JD
    Sem Hop; 1969 May; 45(25):1768-76. PubMed ID: 4308469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mode of action of blood glucose lowering biguanides: clinical aspects].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():678-84. PubMed ID: 4906985
    [No Abstract]   [Full Text] [Related]  

  • 7. Biguanides and the metabolic responses to exercise.
    Botha JL; Vinik AI; van Tonder S; Lund A; Waynik J; Jackson WP
    S Afr Med J; 1978 Mar; 53(9):313-8. PubMed ID: 653542
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the mechanism of action of biguanides in man].
    Beckmann R
    Arzneimittelforschung; 1969 Apr; 19(4):628-33. PubMed ID: 4891526
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Buformin retard in adipose patients with impaired glucose tolerance].
    Schräpler P; Schulz E; Adlung J
    Med Welt; 1975 Oct; 26(42):1919-21. PubMed ID: 1186481
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of biguanides and sulfonylureas on glycemia of subjects with normal metabolism].
    Ezechieli S
    Clin Ter; 1970 Oct; 55(1):33-44. PubMed ID: 4925337
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic effects of butylbiguanide during long lasting intravenous glucose infusion in normal human subjects.
    Gomez F; Felber JP
    Horm Metab Res; 1970 Mar; 2(2):72-5. PubMed ID: 5520911
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oral antidiabetic drugs on glycogen concentration and on glycogenolysis in different rat tissues.
    Kammerer L; Steingaszner O; Lévay J; Dénes R
    Rev Roum Med Intern; 1974; 11(1):145-7. PubMed ID: 4407682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide].
    Losert W; Schillinger E; Kraaz W; Loge O; Jahn P
    Arzneimittelforschung; 1972 Sep; 22(9):1540-52. PubMed ID: 4678618
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action of phenethylbigunide (PEBG). V. Administration in the hyperglycemic rabbit during continous glucose perfusion].
    Fratino P; Rodari T; Maggi G
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1889-91. PubMed ID: 5601975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mode of action of oral antidiabetic drugs].
    Frey H
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of metformin on glucose utilization and body weight].
    Irsigler K
    Dtsch Med Wochenschr; 1970 Oct; 95(43):2169-74. PubMed ID: 5477959
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sympatholytic and hypoglycemic action of certain biguanide derivatives].
    Avakian OM; Pogosian AV; Stepanian NO
    Farmakol Toksikol; 1973; 36(5):707-11. PubMed ID: 4802337
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the release of insulin in patients with fatty liver].
    Waldhäusl W; Irsigler K
    Wien Klin Wochenschr; 1969 Jul; 81(29):544-6. PubMed ID: 5801626
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.